In Vitro Fertilization Market Scope
In vitro fertilization (IVF) is a process of assisted reproductive technology (ART) which include fertilizing using sperm sample and then merging eggs and sperm in a laboratory. It is considered to be one of the most effective way to treat in-fertilization, women with ovarian disorders, some genetic disorder, premature ovarian failures and others such cases which hinders women conceive. The success rate of this process depends on various factors such as cases of infertility, reproductive history, maternal age and others. Considering the technological advancement taking place in in IVF process, its future looks promising with rising birthrate in emerging countries offering lucrative opportunity.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Largest Market | Asia Pacific |
Unit | Value (USD Million) |
Key Companies Profiled | Coopersurgical Inc. (United States), Vitrolife AB (Sweden), Cook Medical Inc. (United States), Fujifilm (United States), Thermo Fisher Scientific Inc. (United States), EMD Sereno Inc. (Merck KGaA) (Germany) and Genea Limited (Australia) |
CAGR | % |
Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global In Vitro Fertilization market throughout the predicted period.
Coopersurgical Inc. (United States), Vitrolife AB (Sweden), Cook Medical Inc. (United States), Fujifilm (United States), Thermo Fisher Scientific Inc. (United States), EMD Sereno Inc. (Merck KGaA) (Germany) and Genea Limited (Australia) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Esco Micro Pte. Ltd. (Singapore), IVFtech APS (Denmark), The Baker Company (United States), Kitazato Corporation (Spain) and Rocket Medical PLC. (United Kingdom).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global In Vitro Fertilization market by Type and Region with country level break-up. On the basis of Type, Frozen non-donor are dominating the market in the year 2023
On the basis of geography, the market of In Vitro Fertilization has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Asia Pacific region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In July 2023,Hong Kong-headquartered investment firm BPEA EQT will acquire a majority stake in India’s largest fertility services provider Indira IVF for an undisclosed sum. Market sources revealed that Indira IVF has been valued at over Rs 10,000 crore. BPEA EQT will pick up around 60 per cent stake for about Rs 6,000 crore. Indira IVF declined to comment on the deal size.
Reproductive technology startup Orchid on announced a comprehensive new genetic test that may help many prospective parents across the U.S. breathe a little easier
Influencing Trend:
IVF for the Prevention of Diseases and Standardization of Processes Resulting in Increased Automation
Market Growth Drivers:
Growing Numbers of Infertility Cases in Couples Owing to Changing Lifestyles and Growing Tendency Among Women to Freeze Their Eggs to Focus on Career
Challenges:
Mild Cramping and Bloating
Restraints:
High Cost of IVF Processes, Lack of Awareness About It in Emerging Countries and Lack of Disposable Income
Opportunities:
Low Cost of Treatment in Asia Pacific's Emerging Countries and Growing Number of Licensed Fertility Clinics
Key Target Audience
In Vitro Fertilization Service Providers, Healthcare/medical Centers, Government Agencies, Research Institutes, Potential Investors and Others